APO RESEARCH · REPORT
Drug-coated Balloon (DCB)
A drug-coated balloon (DCB) is an angioplasty balloon catheter in which an antiproliferative drug is coated onto the balloon surface and delivered to the vessel wall during transient balloon inflation, providing a localized therapeutic effect while leaving no permanent implant behind. The coating is engineered to remain stable on the balloon during tracking and deployment, then rapidly transfer an effective dose into the arterial tissue upon inflation, with the drug retained in the vessel wall to suppress neointimal hyperplasia and reduce restenosis after percutaneous transluminal angioplasty. In clinical use, DCB technology is applied across coronary and peripheral interventions, including femoropopliteal and below-the-knee vessels and selected dialysis-access lesions, and its performance is defined by the balance between deliverability, tissue drug transfer efficiency, and the control of downstream loss of coating material during the procedure.
Product & engineering
Understand the product.
A drug-coated balloon (DCB) is an angioplasty balloon catheter in which an antiproliferative drug is coated onto the balloon surface and delivered to the vessel wall during transient balloon inflation, providing a localized therapeutic effect while leaving no permanent implant behind. The coating is engineered to remain stable on the balloon during tracking and deployment, then rapidly transfer an effective dose into the arterial tissue upon inflation, with the drug retained in the vessel wall to suppress neointimal hyperplasia and reduce restenosis after percutaneous transluminal angioplasty. In clinical use, DCB technology is applied across coronary and peripheral interventions, including femoropopliteal and below-the-knee vessels and selected dialysis-access lesions, and its performance is defined by the balance between deliverability, tissue drug transfer efficiency, and the control of downstream loss of coating material during the procedure.
Selected research
Market Analysis & Forecast
Global Drug-coated Balloon (DCB) Market Analysis and Forecast 2026-2032
Market perspective
A drug-coated balloon (DCB) is an angioplasty balloon catheter in which an antiproliferative drug is coated onto the balloon surface and delivered to the vessel wall during transient balloon inflation, providing a localized therapeutic effect while leaving no permanent implant behind. The coating is engineered to remain stable on the balloon during tracking and deployment, then rapidly transfer an effective dose into the arterial tissue upon inflation, with the drug retained in the vessel wall to suppress neointimal hyperplasia and reduce restenosis after percutaneous transluminal angioplasty. In clinical use, DCB technology is applied across coronary and peripheral interventions, including femoropopliteal and below-the-knee vessels and selected dialysis-access lesions, and its performance is defined by the balance between deliverability, tissue drug transfer efficiency, and the control of downstream loss of coating material during the procedure.
The global Drug-coated Balloon (DCB) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Drug-coated Balloon (DCB) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Europe market for Drug-coated Balloon (DCB) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Asia-Pacific market for Drug-coated Balloon (DCB) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Drug-coated Balloon (DCB) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Drug-coated Balloon (DCB) include Medtronic, Boston Scientific, Becton Dickinson, Biotronik, B. Braun, Philips, Abbott, Eurocor and Yinyi Biotech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Drug-coated Balloon (DCB), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Drug-coated Balloon (DCB), also provides the sales of main regions and countries. Of the upcoming market potential for Drug-coated Balloon (DCB), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drug-coated Balloon (DCB) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drug-coated Balloon (DCB) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Drug-coated Balloon (DCB) sales, projected growth trends, production technology, application and end-user industry.
Drug-coated Balloon (DCB) Segment by Company
Medtronic
Boston Scientific
Becton Dickinson
Biotronik
B. Braun
Philips
Abbott
Eurocor
Yinyi Biotech
Lepu Medical
Grand Pharma
Acotec Scientific
Shenqi Medical
MicroPort
Zylox-Tonbridge Medical
Zhejiang Barty Medical
Drug-coated Balloon (DCB) Segment by Type
Coronary DCB
Peripheral DCB (FP)
Peripheral DCB (BTK)
Drug-coated Balloon (DCB) Segment by Application
Dialysis Access (AVF/AVG)
Femoropopliteal (FP)
Below-the-Knee (BTK)
Drug-coated Balloon (DCB) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug-coated Balloon (DCB) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug-coated Balloon (DCB) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug-coated Balloon (DCB).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Drug-coated Balloon (DCB) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Drug-coated Balloon (DCB) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug-coated Balloon (DCB) sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Coronary DCB
- Peripheral DCB (FP)
- Peripheral DCB (BTK)
Applications
- Dialysis Access (AVF/AVG)
- Femoropopliteal (FP)
- Below-the-Knee (BTK)
Companies covered
- Medtronic
- Boston Scientific
- Becton Dickinson
- Biotronik
- B. Braun
- Philips
- Abbott
- Eurocor
- Yinyi Biotech
- Lepu Medical
- Grand Pharma
- Acotec Scientific
- Shenqi Medical
- MicroPort
- Zylox-Tonbridge Medical
- Zhejiang Barty Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Drug-coated Balloon (DCB) Market by Type
- 1.2.1 Global Drug-coated Balloon (DCB) Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Coronary DCB
- 1.2.3 Peripheral DCB (FP)
- 1.2.4 Peripheral DCB (BTK)
- 1.3 Drug-coated Balloon (DCB) Market by Application
- 1.3.1 Global Drug-coated Balloon (DCB) Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Dialysis Access (AVF/AVG)
- 1.3.3 Femoropopliteal (FP)
- 1.3.4 Below-the-Knee (BTK)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Drug-coated Balloon (DCB) Market Dynamics
- 2.1 Drug-coated Balloon (DCB) Industry Trends
- 2.2 Drug-coated Balloon (DCB) Industry Drivers
- 2.3 Drug-coated Balloon (DCB) Industry Opportunities and Challenges
- 2.4 Drug-coated Balloon (DCB) Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Drug-coated Balloon (DCB) Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Drug-coated Balloon (DCB) Revenue by Region
- 3.2.1 Global Drug-coated Balloon (DCB) Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Drug-coated Balloon (DCB) Revenue by Region (2021-2026)
- 3.2.3 Global Drug-coated Balloon (DCB) Revenue by Region (2027-2032)
- 3.2.4 Global Drug-coated Balloon (DCB) Revenue Market Share by Region (2021-2032)
- 3.3 Global Drug-coated Balloon (DCB) Sales Estimates and Forecasts 2021-2032
- 3.4 Global Drug-coated Balloon (DCB) Sales by Region
- 3.4.1 Global Drug-coated Balloon (DCB) Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Drug-coated Balloon (DCB) Sales by Region (2021-2026)
- 3.4.3 Global Drug-coated Balloon (DCB) Sales by Region (2027-2032)
- 3.4.4 Global Drug-coated Balloon (DCB) Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Drug-coated Balloon (DCB) Revenue by Manufacturers
- 4.1.1 Global Drug-coated Balloon (DCB) Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Drug-coated Balloon (DCB) Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Drug-coated Balloon (DCB) Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Drug-coated Balloon (DCB) Sales by Manufacturers
- 4.2.1 Global Drug-coated Balloon (DCB) Sales by Manufacturers (2021-2026)
- 4.2.2 Global Drug-coated Balloon (DCB) Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Drug-coated Balloon (DCB) Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Drug-coated Balloon (DCB) Sales Price by Manufacturers (2021-2026)
- 4.4 Global Drug-coated Balloon (DCB) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Drug-coated Balloon (DCB) Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Drug-coated Balloon (DCB) Manufacturers, Product Type & Application
- 4.7 Global Drug-coated Balloon (DCB) Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Drug-coated Balloon (DCB) Market CR5 and HHI
- 4.8.2 2025 Drug-coated Balloon (DCB) Tier 1, Tier 2, and Tier 3
5 Drug-coated Balloon (DCB) Market by Type
- 5.1 Global Drug-coated Balloon (DCB) Revenue by Type
- 5.1.1 Global Drug-coated Balloon (DCB) Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Drug-coated Balloon (DCB) Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Drug-coated Balloon (DCB) Revenue Market Share by Type (2021-2032)
- 5.2 Global Drug-coated Balloon (DCB) Sales by Type
- 5.2.1 Global Drug-coated Balloon (DCB) Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Drug-coated Balloon (DCB) Sales by Type (2021-2032) & (k units)
- 5.2.3 Global Drug-coated Balloon (DCB) Sales Market Share by Type (2021-2032)
- 5.3 Global Drug-coated Balloon (DCB) Price by Type
6 Drug-coated Balloon (DCB) Market by Application
- 6.1 Global Drug-coated Balloon (DCB) Revenue by Application
- 6.1.1 Global Drug-coated Balloon (DCB) Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Drug-coated Balloon (DCB) Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Drug-coated Balloon (DCB) Revenue Market Share by Application (2021-2032)
- 6.2 Global Drug-coated Balloon (DCB) Sales by Application
- 6.2.1 Global Drug-coated Balloon (DCB) Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Drug-coated Balloon (DCB) Sales by Application (2021-2032) & (k units)
- 6.2.3 Global Drug-coated Balloon (DCB) Sales Market Share by Application (2021-2032)
- 6.3 Global Drug-coated Balloon (DCB) Price by Application
7 Company Profiles
- 7.1 Medtronic
- 7.1.1 Medtronic Company Information
- 7.1.2 Medtronic Business Overview
- 7.1.3 Medtronic Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Medtronic Drug-coated Balloon (DCB) Product Portfolio
- 7.1.5 Medtronic Recent Developments
- 7.2 Boston Scientific
- 7.2.1 Boston Scientific Company Information
- 7.2.2 Boston Scientific Business Overview
- 7.2.3 Boston Scientific Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Boston Scientific Drug-coated Balloon (DCB) Product Portfolio
- 7.2.5 Boston Scientific Recent Developments
- 7.3 Becton Dickinson
- 7.3.1 Becton Dickinson Company Information
- 7.3.2 Becton Dickinson Business Overview
- 7.3.3 Becton Dickinson Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Becton Dickinson Drug-coated Balloon (DCB) Product Portfolio
- 7.3.5 Becton Dickinson Recent Developments
- 7.4 Biotronik
- 7.4.1 Biotronik Company Information
- 7.4.2 Biotronik Business Overview
- 7.4.3 Biotronik Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Biotronik Drug-coated Balloon (DCB) Product Portfolio
- 7.4.5 Biotronik Recent Developments
- 7.5 B. Braun
- 7.5.1 B. Braun Company Information
- 7.5.2 B. Braun Business Overview
- 7.5.3 B. Braun Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 B. Braun Drug-coated Balloon (DCB) Product Portfolio
- 7.5.5 B. Braun Recent Developments
- 7.6 Philips
- 7.6.1 Philips Company Information
- 7.6.2 Philips Business Overview
- 7.6.3 Philips Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Philips Drug-coated Balloon (DCB) Product Portfolio
- 7.6.5 Philips Recent Developments
- 7.7 Abbott
- 7.7.1 Abbott Company Information
- 7.7.2 Abbott Business Overview
- 7.7.3 Abbott Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Abbott Drug-coated Balloon (DCB) Product Portfolio
- 7.7.5 Abbott Recent Developments
- 7.8 Eurocor
- 7.8.1 Eurocor Company Information
- 7.8.2 Eurocor Business Overview
- 7.8.3 Eurocor Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Eurocor Drug-coated Balloon (DCB) Product Portfolio
- 7.8.5 Eurocor Recent Developments
- 7.9 Yinyi Biotech
- 7.9.1 Yinyi Biotech Company Information
- 7.9.2 Yinyi Biotech Business Overview
- 7.9.3 Yinyi Biotech Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Yinyi Biotech Drug-coated Balloon (DCB) Product Portfolio
- 7.9.5 Yinyi Biotech Recent Developments
- 7.10 Lepu Medical
- 7.10.1 Lepu Medical Company Information
- 7.10.2 Lepu Medical Business Overview
- 7.10.3 Lepu Medical Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Lepu Medical Drug-coated Balloon (DCB) Product Portfolio
- 7.10.5 Lepu Medical Recent Developments
- 7.11 Grand Pharma
- 7.11.1 Grand Pharma Company Information
- 7.11.2 Grand Pharma Business Overview
- 7.11.3 Grand Pharma Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Grand Pharma Drug-coated Balloon (DCB) Product Portfolio
- 7.11.5 Grand Pharma Recent Developments
- 7.12 Acotec Scientific
- 7.12.1 Acotec Scientific Company Information
- 7.12.2 Acotec Scientific Business Overview
- 7.12.3 Acotec Scientific Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 Acotec Scientific Drug-coated Balloon (DCB) Product Portfolio
- 7.12.5 Acotec Scientific Recent Developments
- 7.13 Shenqi Medical
- 7.13.1 Shenqi Medical Company Information
- 7.13.2 Shenqi Medical Business Overview
- 7.13.3 Shenqi Medical Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 Shenqi Medical Drug-coated Balloon (DCB) Product Portfolio
- 7.13.5 Shenqi Medical Recent Developments
- 7.14 MicroPort
- 7.14.1 MicroPort Company Information
- 7.14.2 MicroPort Business Overview
- 7.14.3 MicroPort Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.14.4 MicroPort Drug-coated Balloon (DCB) Product Portfolio
- 7.14.5 MicroPort Recent Developments
- 7.15 Zylox-Tonbridge Medical
- 7.15.1 Zylox-Tonbridge Medical Company Information
- 7.15.2 Zylox-Tonbridge Medical Business Overview
- 7.15.3 Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.15.4 Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Product Portfolio
- 7.15.5 Zylox-Tonbridge Medical Recent Developments
- 7.16 Zhejiang Barty Medical
- 7.16.1 Zhejiang Barty Medical Company Information
- 7.16.2 Zhejiang Barty Medical Business Overview
- 7.16.3 Zhejiang Barty Medical Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.16.4 Zhejiang Barty Medical Drug-coated Balloon (DCB) Product Portfolio
- 7.16.5 Zhejiang Barty Medical Recent Developments
8 North America
- 8.1 North America Drug-coated Balloon (DCB) Market Size by Type
- 8.1.1 North America Drug-coated Balloon (DCB) Revenue by Type (2021-2032)
- 8.1.2 North America Drug-coated Balloon (DCB) Sales by Type (2021-2032)
- 8.1.3 North America Drug-coated Balloon (DCB) Price by Type (2021-2032)
- 8.2 North America Drug-coated Balloon (DCB) Market Size by Application
- 8.2.1 North America Drug-coated Balloon (DCB) Revenue by Application (2021-2032)
- 8.2.2 North America Drug-coated Balloon (DCB) Sales by Application (2021-2032)
- 8.2.3 North America Drug-coated Balloon (DCB) Price by Application (2021-2032)
- 8.3 North America Drug-coated Balloon (DCB) Market Size by Country
- 8.3.1 North America Drug-coated Balloon (DCB) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Drug-coated Balloon (DCB) Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Drug-coated Balloon (DCB) Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Drug-coated Balloon (DCB) Market Size by Type
- 9.1.1 Europe Drug-coated Balloon (DCB) Revenue by Type (2021-2032)
- 9.1.2 Europe Drug-coated Balloon (DCB) Sales by Type (2021-2032)
- 9.1.3 Europe Drug-coated Balloon (DCB) Price by Type (2021-2032)
- 9.2 Europe Drug-coated Balloon (DCB) Market Size by Application
- 9.2.1 Europe Drug-coated Balloon (DCB) Revenue by Application (2021-2032)
- 9.2.2 Europe Drug-coated Balloon (DCB) Sales by Application (2021-2032)
- 9.2.3 Europe Drug-coated Balloon (DCB) Price by Application (2021-2032)
- 9.3 Europe Drug-coated Balloon (DCB) Market Size by Country
- 9.3.1 Europe Drug-coated Balloon (DCB) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Drug-coated Balloon (DCB) Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Drug-coated Balloon (DCB) Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Drug-coated Balloon (DCB) Market Size by Type
- 10.1.1 China Drug-coated Balloon (DCB) Revenue by Type (2021-2032)
- 10.1.2 China Drug-coated Balloon (DCB) Sales by Type (2021-2032)
- 10.1.3 China Drug-coated Balloon (DCB) Price by Type (2021-2032)
- 10.2 China Drug-coated Balloon (DCB) Market Size by Application
- 10.2.1 China Drug-coated Balloon (DCB) Revenue by Application (2021-2032)
- 10.2.2 China Drug-coated Balloon (DCB) Sales by Application (2021-2032)
- 10.2.3 China Drug-coated Balloon (DCB) Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Drug-coated Balloon (DCB) Market Size by Type
- 11.1.1 Asia Drug-coated Balloon (DCB) Revenue by Type (2021-2032)
- 11.1.2 Asia Drug-coated Balloon (DCB) Sales by Type (2021-2032)
- 11.1.3 Asia Drug-coated Balloon (DCB) Price by Type (2021-2032)
- 11.2 Asia Drug-coated Balloon (DCB) Market Size by Application
- 11.2.1 Asia Drug-coated Balloon (DCB) Revenue by Application (2021-2032)
- 11.2.2 Asia Drug-coated Balloon (DCB) Sales by Application (2021-2032)
- 11.2.3 Asia Drug-coated Balloon (DCB) Price by Application (2021-2032)
- 11.3 Asia Drug-coated Balloon (DCB) Market Size by Country
- 11.3.1 Asia Drug-coated Balloon (DCB) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Drug-coated Balloon (DCB) Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Drug-coated Balloon (DCB) Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Drug-coated Balloon (DCB) Market Size by Type
- 12.1.1 SAMEA Drug-coated Balloon (DCB) Revenue by Type (2021-2032)
- 12.1.2 SAMEA Drug-coated Balloon (DCB) Sales by Type (2021-2032)
- 12.1.3 SAMEA Drug-coated Balloon (DCB) Price by Type (2021-2032)
- 12.2 SAMEA Drug-coated Balloon (DCB) Market Size by Application
- 12.2.1 SAMEA Drug-coated Balloon (DCB) Revenue by Application (2021-2032)
- 12.2.2 SAMEA Drug-coated Balloon (DCB) Sales by Application (2021-2032)
- 12.2.3 SAMEA Drug-coated Balloon (DCB) Price by Application (2021-2032)
- 12.3 SAMEA Drug-coated Balloon (DCB) Market Size by Country
- 12.3.1 SAMEA Drug-coated Balloon (DCB) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Drug-coated Balloon (DCB) Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Drug-coated Balloon (DCB) Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Drug-coated Balloon (DCB) Value Chain Analysis
- 13.1.1 Drug-coated Balloon (DCB) Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Drug-coated Balloon (DCB) Production Mode & Process
- 13.2 Drug-coated Balloon (DCB) Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Drug-coated Balloon (DCB) Distributors
- 13.2.3 Drug-coated Balloon (DCB) Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst